ES2059348T3 - Composicion farmaceutica para el tratamiento de cataratas. - Google Patents

Composicion farmaceutica para el tratamiento de cataratas.

Info

Publication number
ES2059348T3
ES2059348T3 ES87117637T ES87117637T ES2059348T3 ES 2059348 T3 ES2059348 T3 ES 2059348T3 ES 87117637 T ES87117637 T ES 87117637T ES 87117637 T ES87117637 T ES 87117637T ES 2059348 T3 ES2059348 T3 ES 2059348T3
Authority
ES
Spain
Prior art keywords
treatment
pharmaceutical composition
waterfalls
cataract
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87117637T
Other languages
English (en)
Inventor
Shinji Terao
Mitsuyoshi Azuma
Noriko Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2059348T3 publication Critical patent/ES2059348T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE CATARATAS, QUE CONTIENE UN COMPUESTO DE LA FOMULA (I) DONDE N ES UN NUMERO ENTERO DE 8 A 20, Y AL USO DEL MISMO. EL COMPUESTO (I) DE ESTA INVENCION TIENE UN EXCELENTE EFECTO TERAPEUTICO CONTRA VARIOS TIPOS DE CATARATA Y POR ELLO PUEDE EMPLEARSE COMO REMEDIO PARA LAS CATARATAS.
ES87117637T 1986-12-03 1987-11-28 Composicion farmaceutica para el tratamiento de cataratas. Expired - Lifetime ES2059348T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28807686 1986-12-03

Publications (1)

Publication Number Publication Date
ES2059348T3 true ES2059348T3 (es) 1994-11-16

Family

ID=17725491

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87117637T Expired - Lifetime ES2059348T3 (es) 1986-12-03 1987-11-28 Composicion farmaceutica para el tratamiento de cataratas.

Country Status (8)

Country Link
US (1) US4826872A (es)
EP (1) EP0270046B1 (es)
KR (1) KR950007099B1 (es)
CN (1) CN1016313B (es)
AT (1) ATE110568T1 (es)
CA (1) CA1300504C (es)
DE (1) DE3750464T2 (es)
ES (1) ES2059348T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
US6046019A (en) * 1991-07-09 2000-04-04 Goumeniouk; Alexander P. Diagnostic kits and methods for making granulocyte cell counts
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
CA2334312A1 (en) 1998-06-26 2000-01-06 Takara Shuzo Co., Ltd. Therapeutic agents
EP1913948B1 (en) * 2002-04-30 2011-10-12 Sifi S.p.A. Re-epithelializing pharmaceutical compositions containing xanthan gum
US20040229814A1 (en) * 2002-08-28 2004-11-18 James Dillon Methods and compositions for protecting against cataract development associated with vitrectomies
WO2007070463A2 (en) * 2005-12-12 2007-06-21 Riolan Technologies, Inc. Compositions, methods and kits for removing debris from an ocular area

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
EP0189272A3 (en) * 1985-01-17 1987-08-19 Fujisawa Pharmaceutical Co., Ltd. New furanone derivatives, processes for preparation thereof and use thereof
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production

Also Published As

Publication number Publication date
CN87107231A (zh) 1988-07-06
CN1016313B (zh) 1992-04-22
US4826872A (en) 1989-05-02
EP0270046A3 (en) 1990-06-13
DE3750464D1 (de) 1994-10-06
KR950007099B1 (ko) 1995-06-30
EP0270046A2 (en) 1988-06-08
ATE110568T1 (de) 1994-09-15
DE3750464T2 (de) 1995-02-09
EP0270046B1 (en) 1994-08-31
KR880007070A (ko) 1988-08-26
CA1300504C (en) 1992-05-12

Similar Documents

Publication Publication Date Title
KR870700620A (ko) 신규 약리학적 화합물
ES2054020T3 (es) Compuestos biologicamente activos.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
ES2149305T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso.
SE8404065D0 (sv) Novel biologically active compounds
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
SE8600658D0 (sv) Novel composition of matter
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
DK74189A (da) Laegemiddel til behandling af mavesaar
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
FI860074A0 (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
ATE18554T1 (de) Optisch aktive imidazolylpropanol-verbindungen und deren herstellung und anwendung.
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.
ATE95697T1 (de) Uricosuretische zusammensetzung.
PH22441A (en) Quinate salts of the antimaterial compound mefloquine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270046

Country of ref document: ES